EDVA
Endovia Health Sciences, Inc.
After-Market
0.24
Endovia Health Sciences, Inc. Profile
About
Info & Links
CEO
William Meissner
Headquarters
Fort Lauderdale, FL 33301, UNITED STATES
Industry
Sector
Auditor
Rose, Snyder & Jacobs LLP
Share holders
280
Employees
3
Endovia Health Sciences, Inc. Statistics
Valuation Measures
Market Capitalization2
1.70M
Enterprise Value
7.63M
Enterprise Value/EBITDA(ttm)
-0.63
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
--
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
-37.53%
Operating Margin(ttm)
--
Profit Margin(ttm)
-37500.66%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
-100.22%
Return on Assets(ttm)
-266.47%
Income Statement
Revenue(ttm)
8.70K
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
-6.80K
EBITDA(ttm)3
-12.04M
Net Income Available to Common(ttm)
-24.93M
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
-1.10
52-Week Change
--
S&P 500 52-Week Change
17.72%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
2.74M
Dividend Yield
0.00%
Float4
1.93M
% Held by Insiders
69.90%
% Held by Institutions
5.77%
Balance Sheet
Total Cash(mrq)
381.20K
Total Cash Per Share(mrq)
0.14
Total Debt(mrq)
6.31M
Total Debt/Equity(mrq)
-40.55%
Current Ratio(mrq)
0.05%
Quick Ratio(mrq)
0.05%
Book Value Per Share(mrq)
-3.82
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.66
Free Cash Flow(ytd)
-2.01M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.